Marius Pharmaceuticals
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8601 Six Forks Rd Ste 630, Raleigh, Nort...Phone Number
(919) 374-1913Website
www.mariuspharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Marius Pharmaceuticals
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies aimed at improving metabolic vitality and well-being. The company focuses on addressing testosterone deficiency with innovative solutions for both men and women, particularly through their proprietary oral testosterone therapy, KYZATREX. This prescription treatment is designed for adult men with low or no testosterone levels due to specific medical conditions. Marius Pharmaceuticals is committed to ongoing research to explore the broader implications of testosterone therapy in various patient populations.Explore more
Marius Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Marius Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Marius Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Check out if Marius Pharmaceuticals is spiking on competitors!
Check if Marius Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Marius Pharmaceuticals recently announced quarterly report
Marius Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Marius Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Marius Pharmaceuticals
Product Launch: Get notified when Marius Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Marius Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Marius Pharmaceuticals
Compare insights from companies similar to Marius Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Marius Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Marius Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Marius Pharmaceuticals.
Marius Pharmaceuticals Tech Stack
A closer look at the technologies used by Marius Pharmaceuticals
See more technologies
Most Recent Scoops
Event
Person-Based
Events, Podcast
Person-Based
Event
Person-Based
Shalin Shah, Chief Executive Officer, appeared on a podcast called "The Human Upgrade with Dave Asprey" on 05/09/2025. Topics discussed include Testosterone, longevity, health, therapy, women.
Events, Podcast
Person-Based
Person-Based
Marius Pharmaceuticals News & Media
New Research from Marius Pharmaceuticals Reveals Major Men's Health Awareness Gap: 65% Have Never Had Their Testosterone Levels Tested
National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily life National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily lifeMarius Pharmaceuticals Announces Key Leadership Expansion and Launch of Marius AI, Positioning the Company as the First AI-Native Pharmaceutical Company
Industry Veterans Join Growing Team as Marius Accelerates Its Mission to Transform Men's Health Industry Veterans Join Growing Team as Marius Accelerates Its Mission to Transform Men's HealthMarius Pharmaceuticals to Initiate Study Evaluating KYZATREX® (testosterone undecanoate) CIII Capsules in Men Ages 65–80
RALEIGH, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced the company will initiate a new post-marketing clinical study for potential label expansion evaluating KYZATREX® (testosterone undecanoate) CIII capsules in men ages 65–80 with hypogonadism. KYZATREX is a prescription drug used to treat adult men who have low or no testosterone levels due to certain medical conditions.Marius Pharmaceuticals CEO Shalin Shah Invited to Speak at Landmark FDA Expert Panel on Testosterone Replacement Therapy for Men
RALEIGH, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced that its Chief Executive Officer, Shalin Shah, will speak at the FDA Expert Panel on Testosterone Replacement Therapy for Men, taking place on December 10, 2025. This landmark event marks a pivotal moment in the advancement of men’s health and represents a major milestone for Marius, which has worked for years to elevate the scientific conversation surrounding testosterone and address longstanding misco
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Marius Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies aimed at improving metabolic vitality and well-being. The company focuses on addressing testosterone deficiency with innovative solutions for both men and women, particularly through their proprietary oral testosterone therapy, KYZATREX. This pres... Read More
